← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dynocardia, Inc.
Newton Center, MA
$6,069,511
Total funding
4
Grants
Funding over time
peak $2.7M · FY2021–24$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
Funding mix
By agency
NIH$5,069,958 · 3
NSF$999,553 · 1
By mechanism
R44$4,570,077 · 2
—$999,553 · 1
SB1$499,881 · 1
Investigators at Dynocardia, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy$1,168,681
R44 · FY2023 · HL
ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy$1,157,562
R44 · FY2024 · HL
Development of a novel cuff-less wrist wearable continuous blood pressure monitor$1,016,328
R44 · FY2022 · HL
SBIR Phase II: Development of motion artifact correction systems for ViTrack: an accurate, continuous, and non-invasive blood pressure monitor$999,553
· FY2024 · TIP
Development of a novel cuff-less wrist wearable continuous blood pressure monitor$973,855
R44 · FY2021 · HL
Design verification and validation of ViTrack - an accurate, continuous, non-invasive blood pressure monitor$499,881
SB1 · FY2024 · HL
Continuous non-invasive assessment of blood pressure profile in persons with Alzheimer's and its related dementias$153,969
R44 · FY2022 · HL
ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy$99,682
R44 · FY2023 · HL